Filing Flows › Genpact (G) › Q1 2025
Genpact (G) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
Genpact (G) reported revenue of $1.2B for the first quarter 2025 (Q1 2025), +7% from a year earlier and -3% from the quarter before. Operating margin was 15.1%, net earnings $131M (10.8% of revenue).
Genpact, Q1 2025: revenue $1.2B (+7% year over year), operating margin 15.1%, net earnings $131M, operating cash flow $40.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2B | -3% | +7% |
| Gross profit | $429M | -4% | +8% |
| Operating profit | $184M | -3% | +15% |
| Net earnings | $131M | -8% | +12% |
| Operating cash flow | $40.4M | -80% | — |
| Free cash flow | $18.5M | -90% | — |
What changed
Revenue was $1.2B in Q1 2025, up 7% year over year and down 3% from the previous quarter. Digital operations was the largest line at 52% of revenue. Data-Tech-AI added $0.06B year over year (up 11%), 69% of the total change.
Gross margin was 35.3%, up 0.3 points from a year earlier. Operating profit was $0.18B, a 15.1% margin (up 1.0 points year over year). Of the extra revenue versus a year earlier, 28% reached operating profit, above the 14% margin then. Operating expenses grew 4% against revenue growth of 7%. The fastest-growing cost line was Other operating costs (+188%). Net earnings were $0.13B, up 12% year over year. The effective tax rate was 25.3%.
Operating cash flow was $0.04B, 31% of net earnings. Non-cash charges added back $0.02B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.13B. Capital expenditures of $0.02B left free cash flow of $0.02B.
Questions
What was Genpact's revenue in the first quarter 2025?
Genpact (G) reported revenue of $1.2B for the first quarter 2025 (Q1 2025), +7% from a year earlier and -3% from the quarter before.
Was Genpact profitable in the first quarter 2025?
Operating profit was $184M (15.1% of revenue) and net earnings $131M.
Source: Genpact 10-Q on SEC EDGAR.